The International journal of prosthodontics · 2022
Which Patient-Related Factors Influence the Outcome of Telescopic-Retained Removable Implant-Supported Dental Prostheses in Edentulous Patients?
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zierden Karina, Wöstmann Bernd, Rehmann Peter
Аннотация
PURPOSE: To survey the clinical performance of telescopic-retained removable implant-supported dental prostheses (TR-RISDPs) in edentulous patients, as well as incidental maintenance measures and technical complications.
MATERIALS AND METHODS: In this retrospective analysis, the former presence of oral cancer, prosthesis location (maxilla or mandible), and participation in a follow-up program were analyzed as possible factors with an influence on survival and maintenance treatments of the TR-RISDPs and dental implants using Kaplan-Meier estimates.
RESULTS: A total of 86 TR-RISDPs (mean follow-up: 4.62 ± 3.24 years; maximum 13.8 years) and 465 implants (mean follow-up: 5.67 ± 3.59 years; maximum 16.5 years) were observed. Six (6.9%) of the TR-RISDPs had to be remade, and 11 (2.3%) implants failed. Regular attendance in the follow-up program showed significantly higher survival times and fewer maintenance treatments for the TRRISDPs (P < .05). Implants in patients with former oral cancer showed significantly lower survival times (P < .001).
CONCLUSIONS: TR-RISDPs in edentulous patients show excellent clinical outcomes. Regular check-ups are decisive for success.
MATERIALS AND METHODS: In this retrospective analysis, the former presence of oral cancer, prosthesis location (maxilla or mandible), and participation in a follow-up program were analyzed as possible factors with an influence on survival and maintenance treatments of the TR-RISDPs and dental implants using Kaplan-Meier estimates.
RESULTS: A total of 86 TR-RISDPs (mean follow-up: 4.62 ± 3.24 years; maximum 13.8 years) and 465 implants (mean follow-up: 5.67 ± 3.59 years; maximum 16.5 years) were observed. Six (6.9%) of the TR-RISDPs had to be remade, and 11 (2.3%) implants failed. Regular attendance in the follow-up program showed significantly higher survival times and fewer maintenance treatments for the TRRISDPs (P < .05). Implants in patients with former oral cancer showed significantly lower survival times (P < .001).
CONCLUSIONS: TR-RISDPs in edentulous patients show excellent clinical outcomes. Regular check-ups are decisive for success.